Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLunglife Ai Regulatory News (LLAI)

  • There is currently no data for LLAI
12
Date   Source Headline
2nd May 20237:00 amRNSConfirmation of AGM
6th Apr 20233:50 pmRNSPublication of Annual Report & Notice of AGM
14th Mar 20237:00 amRNSAppointment of Joint Broker
13th Mar 20237:00 amRNSStatement re. Silicon Valley Bank
7th Mar 20237:00 amRNSHealth economics publication
27th Feb 20237:00 amRNSData on cost-effectiveness of LungLB®
20th Feb 20237:00 amRNSPreliminary results for year ended 31 Dec 2022
8th Feb 20237:00 amRNSNotice of Results
7th Dec 20222:37 pmRNSHolding(s) in Company
30th Nov 20227:00 amRNSFinal Pricing Determination
30th Nov 20227:00 amRNSTotal Voting Rights
15th Nov 20227:00 amRNSBlock Listing Six Monthly Return
3rd Nov 20227:00 amRNSDirector share purchases
17th Oct 20227:00 amRNSParticipation in National Cancer Institute’s EDRN
26th Sep 20227:00 amRNSHalf-year Report
9th Sep 20227:00 amRNSNotice of Results
2nd Sep 20227:00 amRNSNew York State approval for commercial testing
16th May 20227:00 amRNSBlock Listing Six Monthly Return
11th May 20223:17 pmRNSResult of AGM
8th Apr 20227:00 amRNSPublication of AR and Accounts & Notice of AGM
28th Mar 20227:00 amRNSPreliminary Results
17th Mar 20227:00 amRNSVA sites in validation study; SAB appointment
2nd Feb 20227:00 amRNSFirst patient enrolment for LungLB® study
4th Jan 20227:00 amRNSCPT® Code granted by American Medical Association
19th Nov 20217:00 amRNSLungLife AI Laboratory achieves CAP accreditation
10th Nov 20217:00 amRNSBlock Listing Application
12th Oct 20217:00 amRNSPLA Code application submitted
9th Sep 20217:00 amRNSHalf-year Report
3rd Sep 20217:00 amRNSNotice of Results
28th Jul 20213:08 pmRNSHolding(s) in Company
12th Jul 20219:15 amRNSHolding(s) in Company
9th Jul 20213:35 pmRNSHolding(s) in Company
8th Jul 20213:45 pmRNSHolding(s) in Company
8th Jul 20218:00 amRNSDirector/PDMR Shareholding
8th Jul 20217:00 amRNSAdmission to AIM & First Day of Dealings
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.